Our findings beg the question of how the smArf protein, which lacks N-terminal residues required for p53 activation and is primarily localized to the inner matrix of (maternally inherited) mitochondria [1, 2], would mediate residual tumor suppressive effects in irradiated smArf female hosts that are not observed in the Arf-null setting. The gene discussed is TP53; the disease is neoplasm.